articleNature MedicineSep 7, 2023GREEN OA

Senolytic therapy in mild Alzheimer’s disease: a phase 1 feasibility trial

MMMitzi M. GonzalesVRValentina R. GarbarinoTFTiffany F. KautzJPJuan Pablo PalaviciniMLMarisa Lopez‐Cruzan

The University of Texas Health Science Center at San Antonio · Longevity Biotech (United States) · +7 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

234
total citations
FWCI
39.66
Percentile
100%
References
62
Citations per year

Authors

20

Topics & keywords

Topics
Keywords
  • Medicine
  • Disease
  • Clinical trial
  • Alzheimer's disease
  • Oncology
  • Internal medicine
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding